NCT07477457 2026-03-17
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
Memorial Sloan Kettering Cancer Center
National Cancer Institute, Egypt
National Institutes of Health Clinical Center (CC)
Grupo de Apoio ao Adolescente e a Crianca com Cancer
Royal Marsden NHS Foundation Trust
HaEmek Medical Center, Israel